Business Context and Reporting Period
This Form 8-K Current Report from Nephros, Inc. (Delaware) covers events occurring on March 3, 2011. The filing details the conclusion of a rights offering and a subsequent private placement transaction with the company's largest stockholder, Lambda Investors, LLC.
Key Financial Metrics and Capital Events
- Rights Offering Proceeds: Gross proceeds of approximately $2.0 million from the sale of 99,297,082 units.
- Private Placement Proceeds: Aggregate purchase price of approximately $1.2 million from Lambda Investors, LLC for 60,194,266 units.
- Unit Structure: Each unit consists of one share of common stock and a warrant to purchase 0.924532845 shares at an exercise price of $0.02 per share for five years.
- Subscription Price: $0.02 per unit for both the rights offering and the private placement.
- Operational Metrics: The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity figures.
Material Changes and Transaction Details
The primary material change is the successful completion of the rights offering, which expired on March 3, 2011. Stockholders subscribed for 99,297,082 units, and the company accepted all basic subscription rights and oversubscription privileges. Additionally, Lambda Investors, LLC agreed to purchase 60,194,266 units in a private placement exempt from registration under Section 4(2) of the Securities Act. These securities are classified as "restricted securities."
Outlook, Risks, and Management Commentary
Management commentary is limited to the announcement of the transaction results. The filing incorporates a press release (Exhibit 99.1) for further details. No specific forward-looking guidance, risk factors, or contingencies are explicitly detailed within the text of this 8-K, other than the standard nature of restricted securities issued in the private placement.
Investor Verification Checklist
- Verify the total dilution impact from the issuance of approximately 159.5 million units (99.3M from rights offering + 60.2M from private placement).
- Confirm the status of the $3.2 million in total gross proceeds raised ($2.0M + $1.2M) and its intended use.
- Review the attached Press Release (Exhibit 99.1) for management's specific commentary on the capital raise.
- Check subsequent filings for the actual issuance of shares and warrants to ensure the transactions closed as reported.